Published in:
01-03-2013 | Short Communication
Efficacy of a protocol including heparin ointment for treatment of multikinase inhibitor-induced hand–foot skin reactions
Published in: Supportive Care in Cancer | Issue 3/2013
Login to get accessAbstract
Purpose
The purpose of this study is to evaluate the efficacy of a protocol including topical heparin therapy for hand–foot skin reactions (HFSR) during multikinase (MKI) treatment.
Methods
We prospectively collected 26 patients who had HFSRs during treatment with the MKIs, sunitinib, sorafenib, or axitinib. The age distribution ranged from 46 to 87 years, with a mean of 66 years. The distribution of HFSR severity was 12 patients with grade 1, 12 with grade 2, and 2 with grade 3. A heparin-containing topical ointment treatment, combined with hand–foot shock absorbers and skin moisturizers, was used at the lesion sites. Changes in the grade of HFSR, MKI dosage, and interruptions of MKI therapy were recorded.
Results
The results showed that 66.7 % of grade 1 patients were cured of disease, 83.3 % of grade 2 patients had improved symptoms, and both grade 3 patients (100 %) had improved symptoms and were downgraded to grade 2. Four (15.4 %) patients required reduction of MKI dosage, but there were no treatment interruptions or dropouts.
Conclusion
Our protocol is beneficial in promoting resolution of HFSRs induced by MKIs. Further validation in large control studies should be investigated.